The Enterprise Value as of December 2025 (TTM) for Aprea Therapeutics, Inc. (APRE) is -10063033.00

According to Aprea Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is -10063033.00. This represents a change of 52.05% compared to the average of -6618457.03 of the last 4 quarters.

Aprea Therapeutics, Inc. (APRE) Historical Enterprise Value (quarterly & annually)

How has APRE Enterprise Value performed in the past?

The mean historical Enterprise Value of Aprea Therapeutics, Inc. over the last ten years is 158.21M. The current -10063033.00 Enterprise Value has changed -736.05% with respect to the historical average. Over the past ten years (40 quarters), APRE's Enterprise Value was at its highest in in the December 2019 quarter at 802.85M. The Enterprise Value was at its lowest in in the December 2022 quarter at -27907755.94.

Aprea Therapeutics, Inc. (APRE) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Aprea Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Aprea Therapeutics, Inc. (APRE) Average Enterprise Value

How has APRE Enterprise Value performed in the past?

The current Enterprise Value of Aprea Therapeutics, Inc. (APRE) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Aprea Therapeutics, Inc. (APRE) Enterprise Value vs. Peers

How is APRE’s Enterprise Value compared to its peers?

Aprea Therapeutics, Inc.’s Enterprise Value is greater than Acurx Pharmaceuticals, Inc. (-5901286277.00), less than BioCardia, Inc. (3.88M), less than Kiora Pharmaceuticals, Inc. (7.29M), less than Galecto, Inc. (22.83M), less than Adial Pharmaceuticals, Inc. (3.22M), less than IN8bio, Inc. (702.60K), less than Creative Medical Technology Holdings, Inc. (-815059.00), less than HCW Biologics Inc. (10.10M), less than Aptevo Therapeutics Inc. (66.93M), greater than TransCode Therapeutics, Inc. (-2827998091.00),

Build a custom stock screener for Aprea Therapeutics, Inc. (APRE) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Aprea Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Aprea Therapeutics, Inc. (APRE) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Aprea Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.